FDA Drug Application (020538) for VIVELLE-DOT by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number020538
Product Number005
FormFILM, EXTENDED RELEASE;TRANSDERMAL
Dosage0.0375MG/24HR
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB1 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameVIVELLE-DOT
Active IngredientESTRADIOL

Active IngredientCount
List of drugs with Active Ingredient ESTRADIOL27


Back to FDA Applications sponsored by NOVARTIS